CagriSema Yields Nearly 16% Weight Loss in Phase 3 REDEFINE 2 Trial US$ 22.40 Min. order: 1 piece ★★★★★ 4.7 (24 reviews) Sold : Login>>
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond - Metabolism US$ 22.18 Min. order: 1 piece ★★★★★ 4.1 (140 reviews) Sold : Login>>
CagriSema Demonstrates Significant Weight Loss at 68 Weeks US$ 25.57 Min. order: 1 piece ★★★★★ 4.8 (26 reviews) Sold : Login>>
Pharmacotherapy in Obesity Management US$ 24.39 Min. order: 1 piece ★★★★★ 4.4 (283 reviews) Sold : Login>>
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 25.09 Min. order: 1 piece ★★★★★ 4.0 (196 reviews) Sold : Login>>